Topical delivery of selected growth factors
Date
2010Author
Van Niekerk, L.
Campell, B.
Gerber, M.
Du Plessis, L.H.
Du Plessis, J.
Metadata
Show full item recordAbstract
Growth factors can benefit from controlled release admin-
istration technologies (i.e. topical or transdermal delivery).
When compared with other epithelial membranes, the skin
has less enzymatic activity and so provides a more stable
dosage medium and prolongs the delivery. The growth
factors that were considered during this study are used for
the treatment of alopecia (IGF-1, VEGF and KGF) and
pigmentation (TNF-a & TGF-b)
URI
http://hdl.handle.net/10394/26827https://onlinelibrary.wiley.com/doi/epdf/10.1211/jpp.62.06.0016
https://doi.org/10.1211/jpp.62.06.0016
https://www.researchgate.net/publication/265612459_Topical_delivery_of_selected_growth_factors